Evidence suggests that psilocybin-assisted therapy for those who have not responded to standard interventions may be beneficial.
|Articles|April 8, 2021
- March 2021
- Volume 89
- Issue 03
March 2021 Pet Peeves
Pet Peeves for March 2021, brought to you by The Sassy Pharmacist.
Advertisement
Slippery Slope
When my mask starts slipping off my nose when counseling a patient and they threaten to complain to management.
Misinformed
When patients ask about the dosing of random supplements needed “to prevent COVID-19.”
E-Prescribe Please
I can’t stand when physicians give patients with COVID-19 hard copy prescriptions. We don’t have a drive through, so they come in the store.
Articles in this issue
over 5 years ago
Gavreto From Blueprint Medicines Corporationover 5 years ago
Interactives Case Studies (March 2021)over 5 years ago
OTC Cases: March 2021 PT Retailover 5 years ago
Another Pandemic Rages on Beyond Our Consciousnessover 5 years ago
Pharmacists Play a Key Role in Mental Healthover 5 years ago
Psychiatric Pharmacy Involves Advanced Clinical Trainingover 5 years ago
Rx Product News: March 2021over 5 years ago
Generic Product News: March PT Retail 2021over 5 years ago
OTC Product News: PT Retail March 2021Advertisement
Related to this article
Investigational antiamyloid monoclonal antibodies may offer a novel pathway to disease reversal.
Increasingly, pharmacists are leading the obesity management team.
A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
2
Expert Q&A: Pharmacists Address Pneumococcal Vaccine Hesitancy and Screening Complexity in Transitions of Care
3
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
4
Semaglutide Linked to Up to 40% Fewer Asthma Attacks, Real-World Data Show
5